Larimar Therapeutics, Inc. Gains 61.25%
Wed, Feb 25, 2026 at 07:32 PM
Larimar Therapeutics, Inc. (LRMR:NASDAQ) shot up at $5.95, representing a gain of 61.2%. On Wed, Feb 25, 2026, LRMR:NASDAQ hit a New 2-Week High of $5.95. The stock got featured on our News Catalysts scanner on Wed, Feb 25, 2026 at 06:56 PM in the 'PUBLIC OFFERING' category. From Wed, Feb 11, 2026, the stock recorded 33.33% Up Days and 30.00% Green Days
About Larimar Therapeutics, Inc. (LRMR:NASDAQ)
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases.
Top 10 Gainers:
- XWELL, Inc. (XWEL:NASDAQ), 220.11%
- SRAX, Inc. (SRAX:NASDAQ), 113.46%
- Braiin Limited (BRAI:NASDAQ), 79.35%
- Larimar Therapeutics, Inc. (LRMR:NASDAQ), 61.25%
- Cardio Diagnostics Holdings, Inc. (CDIO:NASDAQ), 60.42%
- VS MEDIA Holdings Limited (VSME:NASDAQ), 52.07%
- Rayonier Advanced Materials Inc. (RYAM:NYSE), 42.68%
- Clear Secure, Inc. (YOU:NYSE), 38.96%
- N2OFF, Inc. (NITO:NASDAQ), 38.64%
- Rocky Brands, Inc. (RCKY:NASDAQ), 37.35%